Table 4.
Allergy and HPV status | Oral cavity | Oropharynx | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cases exposed | Controls exposed | OR | 95% CI | Cases exposed | Controls exposed | OR | 95% CI | |||||
N | %b | n | %b | n | %b | n | %b | |||||
Any allergies | ||||||||||||
HPV-16 Serology | ||||||||||||
positive | 44 | 39.6 | 98 | 50.3 | 0.78 | (0.46–1.32) | 35 | 44.3 | 98 | 50.3 | 0.85 | (0.48–1.51) |
negative | 50 | 43.1 | 191 | 52.0 | 0.69 | (0.43–1.10) | 24 | 44.4 | 191 | 52.0 | 0.68 | (0.36–1.29) |
HPV DNAc | ||||||||||||
positive | 6 | 54.6 | 306 | 49.9 | 0.99 | (0.28–3.45) | 17 | 56.7 | 306 | 49.9 | 1.27 | (0.59–2.72) |
negative | 58 | 41.7 | 306 | 49.9 | 0.78 | (0.52–1.18) | 23 | 50.0 | 306 | 49.9 | 0.84 | (0.43–1.63) |
Airborne allergiesd | ||||||||||||
HPV-16 Serology | ||||||||||||
positive | 20 | 18.0 | 64 | 32.8 | 0.58 | (0.31–1.10) | 18 | 22.8 | 64 | 32.8 | 0.70 | (0.36–1.35) |
negative | 30 | 25.9 | 127 | 34.6 | 0.77 | (0.46–1.29) | 10 | 18.5 | 127 | 34.6 | 0.43 | (0.19–0.95) |
HPV DNAc | ||||||||||||
positive | 5 | 45.5 | 202 | 33.0 | 1.93 | (0.54–6.93) | 10 | 33.3 | 202 | 33.0 | 0.85 | (0.38–1.92) |
negative | 29 | 20.9 | 202 | 33.0 | 0.65 | (0.40–1.06) | 10 | 21.7 | 202 | 33.0 | 0.54 | (0.24–1.21) |
Adjusted for age, sex, race, education, pack years of smoking, smoking status (ever/never), and average alcoholic drinks per week.
Percentages reflect the proportion of the whole in each category made up by the “n” to the left of each”%.” Unexposed percentages are the complement of percentages shown.
HPV types 16, 18, 31, 33, or 35. No HPV DNA data were available for controls.
Includes allergies to pollens, dust and mold.